PEB 6.16% 15.5¢ pacific edge limited ordinary shares

Ann: GENERAL: PEB: Hershey Center for Applied Res

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 2
    • Release Date: 01/02/12 11:46
    • Summary: GENERAL: PEB: Hershey Center for Applied Research Prepares to Welcome PEB
    • Price Sensitive: No
    • Download Document  3.36KB
    					
    
    PEB
    01/02/2012 09:46
    GENERAL
    
    REL: 0946 HRS Pacific Edge Limited
    
    GENERAL: PEB: Hershey Center for Applied Research Prepares to Welcome PEB
    
    Hershey Center for Applied Research Prepares to Welcome Pacific Edge
    
    HERSHEY, Pa. - Hershey Center for Applied Research (HCAR) prepares to welcome
    Pacific Edge to its thriving research facility in Hershey. Pacific Edge plans
    to open its first US franchise to market the company's bladder cancer
    detection test, Cxbladder(R), to urologists in the United States by the end
    of the year.
    
    Looking to build a better understanding of the US marketplace, Pacific Edge
    chose to bring its product to Hershey because of HCAR's direct engagement in
    nearly every aspect of the company's US commercialization to date.
    
    HCAR Executive Director, Jack Atchason said, "Convincing a company like
    Pacific Edge to open a facility in any location takes strong alignment of the
    location with the business needs, a strong value proposition aligned to these
    business needs, resources and support from all partners, and differentiators
    from other competitive locations".
    
    Pacific Edge plans to set up shop adjacent to HCAR's new Technology Suites.
    This EDA-supported (Economic Development Administration of the Department of
    Commerce) project will open in August and provide subsidized lab and office
    suites for technology companies. The 11,348 square-foot Pacific Edge facility
    will serve as an office and processing facility for the analysis of the
    Cxbladder(R) test. The test utilizes the expression of genes in the patients'
    urine to detect the presence of bladder cancer accurately and non-invasively.
    
    Planning and construction for the new facility is currently underway.
    
    ABOUT HERSHEY CENTER FOR APPLIED RESEARCH
    
    As a Wexford Science and Technology, LLC and The Hershey Trust Company joint
    development project, the Hershey Center for Applied Research (HCAR) has a
    strategic partnership with Penn State University and the Penn State Milton S.
    Hershey Medical Center and offers domestic and international-based tenants
    access to advanced technology and other research resources, and immerses them
    in a climate of innovation.
    
    With an ideal east-coast location convenient to New York, Philadelphia,
    Baltimore and Washington D.C., Hershey is an emerging research hotspot that
    offers access to a well-educated and stable workforce. By leasing fully
    customizable research, manufacturing and office space while also providing
    integrated strategic business services tailored to each tenant, HCAR helps
    early stage to mature life sciences; nanotech and clean tech companies
    innovate and grow.
    
    www.HersheyResearch.com
    
    ABOUT PACIFIC EDGE
    
    Pacific Edge Limited (NZX: PEB) is a New Zealand based cancer diagnostic
    company specializing in the discovery and commercialization of diagnostic and
    prognostic technology for the early detection and monitoring of cancer.
    Products in development and in clinical trials are accurate and simple to use
    genomic and proteomic tools for the earlier detection, improved
    characterization and better management of gastric, bladder, colorectal
    cancers and melanoma. The company has recently completed and released its
    first product for the detection of bladder cancer, Cxbladder(R) and is
    actively marketing the product to urologists in New Zealand, Australia and
    soon to be Spain and Portugal.
    
    www.pacificedge.co.nz
    End CA:00219065 For:PEB    Type:GENERAL    Time:2012-02-01 09:46:02
    				
 
watchlist Created with Sketch. Add PEB (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.